Madrigal Pharmaceuticals, Inc. (MDGL) stock
MDGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/304% above fair value
$421.99−1.97 (-0.46%)
Close on Nov 17, 2026Market cap $9.75BP/E –Yield –
Madrigal Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Madrigal Pharmaceuticals's market cap was $10.00B on Nov 11, 2026, against $13.55B a year earlier. Over the last 5 years it ranged from $970.81M to $13.55B, with a median of $5.15B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $10.00B | -24.4% |
| 2025 | Dec 31, 2025 | $13.22B | +96.5% |
| 2024 | Dec 31, 2024 | $6.73B | +57.2% |
| 2023 | Dec 29, 2023 | $4.28B | -13.8% |
| 2022 | Dec 30, 2022 | $4.96B | +247.5% |
| 2021 | Dec 31, 2021 | $1.43B | -16.9% |
| 2020 | Dec 31, 2020 | $1.72B | +22.3% |
| 2019 | Dec 31, 2019 | $1.41B | -19.0% |
| 2018 | Dec 31, 2018 | $1.74B | +51.3% |
| 2017 | Dec 29, 2017 | $1.15B | +565.3% |
| 2016 | Dec 30, 2016 | $172.40M | +339.2% |
| 2015 | Dec 31, 2015 | $39.25M | -83.3% |
| 2014 | Dec 31, 2014 | $234.89M | -20.3% |
| 2013 | Dec 31, 2013 | $294.73M | -35.1% |
| 2012 | Dec 31, 2012 | $454.32M | +141.5% |
| 2011 | Dec 30, 2011 | $188.15M | +10.7% |
| 2010 | Dec 31, 2010 | $169.96M | – |
See a number that looks wrong?